What is SCT (Cognitive Disengagement Syndrome)?

Your mind doesn't race at a thousand miles an hour. It crawls. There's no internal chaos, just fog. You stare at nothing, and it isn't that a thousand thoughts are competing, it's that you've quietly disconnected from all of them.

This is SCT, sluggish cognitive tempo, now formally renamed Cognitive Disengagement Syndrome (CDS). Almost nobody knows it exists, because the DSM-5 leaves it out entirely.

Not ADHD, though the two can overlap

For decades, SCT symptoms got filed under inattentive ADHD. Recent research shows they belong to a neurologically distinct condition. A 2023 study makes the split concrete. 52% of people with SCT do not meet the criteria for ADHD, and 65% of people with ADHD do not meet the criteria for SCT (Becker et al., 2023).

So these are two different things that happen to co-occur. Among youth with ADHD, 25 to 40% carry elevated SCT symptoms, and 46% of adults with ADHD show comorbid SCT.

Barkley's nine core symptoms

Russell Barkley, who pioneered the research here, laid out nine fundamental symptoms:

1. Daydreaming instead of concentrating
2. Trouble staying alert or awake when things get boring
3. Getting confused easily
4. Getting bored easily
5. Feeling spacey or in a fog
6. Frequent lethargy
7. Being underactive, running on less energy than other people
8. Moving slowly
9. Not processing information quickly or accurately

What ties them together is a single thread. Low tonic arousal, slowed cognitive processing, and a kind of mental disconnection from whatever's happening around you.

The neurological difference from ADHD

The crux is that SCT and ADHD rest on different neurobiological foundations. Inattentive ADHD runs on massive executive deficits across working memory, inhibition and planning, on dopamine and norepinephrine dysregulation in the prefrontal cortex, on internal racing thoughts, and on trouble that worsens as cognitive load climbs. SCT runs on something else entirely. Problems with tonic arousal, slowed mental processing, mental fog and daytime sleepiness, and disengagement from the environment that often takes the form of maladaptive daydreaming.

The imaging tracks that divide. A 2015 neuroimaging study tied SCT to decreased activity in the left superior parietal lobule, a different region from the ones disrupted in classic ADHD. Research in 2018 went further, linking SCT to specific parts of the frontal lobes that differ from ADHD neuroanatomy.

Why nobody talks about it

The DSM-5 doesn't recognise SCT as an independent diagnosis. The reason is institutional rather than scientific, the manual is a political consensus committee, not pure science. Research on SCT has accelerated enormously over the past two decades, but the psychiatric establishment moves at its own glacial pace. In 2023, a scientific working group formally recommended renaming the condition from "Sluggish Cognitive Tempo" to "Cognitive Disengagement Syndrome" (CDS), both to fit current science and to drop the stigma baked into the old name.

Genetics and heritability

A recent twin study suggests SCT is almost as heritable as ADHD. It's genetically influenced, but with a strong contribution from non-shared environmental factors. It shares some genes with ADHD without matching its genetic profile. Related conditions, then, but distinct ones.

Comorbidities and how it plays out

People with pure SCT, without ADHD, carry a particular load:

• More anxiety and depression than the pure ADHD group
• More sleep difficulties
• Fewer executive deficits than ADHD

People with comorbid SCT and ADHD face a heavier version:

• Greater functional impairment than either condition on its own
• A higher risk of internet and gaming addiction
• More academic and social difficulty

That addiction link isn't hand-waving. A 2023 study of medical students and residents found SCT symptoms more strongly associated with internet and gaming addiction than ADHD symptoms were.

So what's the real cognitive deficit

A 2022 review of the neuropsychological research set out to pin down the core deficit in SCT, and the answer surprised people. It isn't general processing speed, despite what the old name implies. It's arousal and vigilance, the difficulty of holding an optimal alert state. And it's sustained attention, though not the "I get distracted" kind so much as the "I disconnect" kind.

The distinction matters. In ADHD you lose the thread because your attention jumps to some internal or external stimulus. In SCT your cortical arousal level itself drops, and you disengage completely.

Do stimulants work

The old assumption was that SCT didn't respond well to stimulants. Recent research pushes back. A placebo-controlled study of lisdexamfetamine (Vyvanse) in adults with comorbid ADHD and SCT reported a 30% reduction in self-reported SCT symptoms alongside a 40% reduction in ADHD symptoms. It was the first study to show SCT improving after stimulant therapy in adults with ADHD.

Other medications are on the table. Atomoxetine (Strattera), a non-stimulant that acts on norepinephrine. Viloxazine (Qelbree), a norepinephrine modulator. Methylphenidate (Ritalin), which may help with focus and attention. The honest caveat is that the response varies. Some people do well, others don't, and the response profile may look different from pure ADHD.

SCT in children versus adults

In children, SCT brings more social rejection, with kids seen as "slow" or "weird," less participation in class, and weaker academic performance that comes more from slowness than from executive deficits. In adults it shifts shape. Work suffers because they read as unproductive, relationships strain because partners experience them as "absent," and the risk of depression and social isolation rises. The pattern sticks around with age. It doesn't fade the way hyperactivity does in ADHD.

Where the problem actually sits in the brain

The research points to the posterior attention networks in the parietal lobe being more compromised in SCT than the prefrontal cortex is. That's the mirror image of ADHD, where the prefrontal cortex and executive functions form the heart of the problem. The posterior attention network handles spatial orientation and the processing of external stimuli, so when it falters, you disengage from your surroundings.

Why telling SCT and ADHD apart is worth the trouble

It changes the diagnosis. Mental fog and slowness without massive executive deficits may point to pure SCT. Having both may mean comorbidity, the 46% of cases, and the treatment can differ accordingly. It changes that treatment in practice, since stimulants may work but at a different dose or type, since therapy should target arousal and engagement rather than only executive compensation, and since behavioural activation strategies may beat organisational techniques. And it changes how you read yourself. You're not lazy or unmotivated. Your cortical arousal level is dysregulated. That's neurobiology, not personality.

The name change, from SCT to CDS

In 2023 an international working group officially recommended switching the name to Cognitive Disengagement Syndrome (CDS). "Sluggish" carries offensive connotations. "Cognitive tempo" misses the essence, since this isn't simply slowness. "Cognitive disengagement" captures the central phenomenon far better. The scientific community is steadily adopting CDS as the official term.

What to do if this sounds like you

SCT and CDS aren't in the DSM-5, but that doesn't make the condition unreal or put help out of reach. A few practical moves:

1. Find informed professionals, because not every psychiatrist knows about SCT
2. Point to Barkley's research, and use his scale to assess your symptoms
3. Consider comorbidity with ADHD, given that 30 to 50% of cases are comorbid
4. Try treatment empirically, since the response to stimulants can itself be informative

For resources, look to Barkley's Adult SCT Rating Scale, a validated instrument, to online communities built around SCT and CDS, and to recent papers on CDS, using the new term when you search.

The research is moving fast. Every year adds more evidence that SCT, or CDS, is a real and distinct neurobiological condition that deserves both recognition and treatment of its own.